Literature DB >> 18830939

The MUC gene family: their role in the diagnosis and prognosis of gastric cancer.

Shantibhusan Senapati1, Poonam Sharma, Sangeeta Bafna, Hemant K Roy, Surinder K Batra.   

Abstract

Early diagnosis of gastric cancer and its differential diagnosis from other non-malignant gastric diseases like gastritis is still a major clinical problem. Most patients are asymptomatic in the early stages of gastric cancer, and there is no reliable marker available for the early and specific diagnosis of gastric cancer. Many attempts have been made to define the biological profile of gastric cancer to improve the chances of its early diagnosis, prognosis and treatment. Several studies have shown the aberrant expression profile of mucins in different malignancies, suggesting that mucins have a great potential to be used as a diagnostic and prognostic marker in gastric cancer. In this review, we have briefly described the different types of gastric adenocarcinomas and the progression of gastric cancer. Furthermore, the role of mucins and their related carbohydrate epitope is discussed in the normal stomach and in the diagnosis and prognosis of gastric adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830939     DOI: 10.14670/HH-23.1541

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  17 in total

Review 1.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

Review 2.  Mucins in pancreatic cancer and its microenvironment.

Authors:  Sukhwinder Kaur; Sushil Kumar; Navneet Momi; Aaron R Sasson; Surinder K Batra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-16       Impact factor: 46.802

Review 3.  Role of mucins in the skin during benign and malignant conditions.

Authors:  Subhankar Chakraborty; Neelima Bonthu; Benjamin J Swanson; Surinder K Batra
Journal:  Cancer Lett       Date:  2010-12-13       Impact factor: 8.679

4.  Immunity and immune suppression in human ovarian cancer.

Authors:  Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

5.  Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.

Authors:  Mirte M Streppel; Audrey Vincent; Radha Mukherjee; Nathaniel R Campbell; Shih-Hsun Chen; Konstantinos Konstantopoulos; Michael G Goggins; Isabelle Van Seuningen; Anirban Maitra; Elizabeth A Montgomery
Journal:  Hum Pathol       Date:  2012-04-26       Impact factor: 3.466

6.  Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity.

Authors:  Silvia Resta-Lenert; Srustidhar Das; Surinder K Batra; Samuel B Ho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-10       Impact factor: 4.052

Review 7.  Mucin-interacting proteins: from function to therapeutics.

Authors:  Shantibhusan Senapati; Srustidhar Das; Surinder K Batra
Journal:  Trends Biochem Sci       Date:  2009-11-11       Impact factor: 13.807

Review 8.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

9.  Dentigerous cyst exhibiting prominent mucous cell metaplasia: report of a unique case mimicking central mucoepidermoid carcinoma.

Authors:  Hiroshi Harada; Toshiyuki Kihara; Hideyuki Abe; Akihiko Kawahara; Jun Akiba; Akira Kurose
Journal:  Med Mol Morphol       Date:  2021-01-12       Impact factor: 2.309

10.  Pathobiological implications of MUC16 expression in pancreatic cancer.

Authors:  Dhanya Haridas; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Satyanarayana Rachagani; Eric Cruz; Sushil Kumar; Srustidhar Das; Subodh M Lele; Judy M Anderson; Uwe A Wittel; Michael A Hollingsworth; Surinder K Batra
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.